Romain Schollhammer

Comparison of⁶⁸Ga-PSMA-617 PET/CT and⁶⁸Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study

Romain Schollhammer, G. Robert, Julien Asselineau et al. · Journal of Nuclear Medicine · 2022 · 47 citations · Full text

Medicine, Nuclear Medicine, Urology +17

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples

Clément Morgat, Romain Schollhammer, Gaëtan MacGrogan et al. · PLoS ONE · 2019 · 38 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples

Romain Schollhammer, Henri de Clermont Gallerande, Mokrane Yacoub et al. · EJNMMI Research · 2019 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS₁-Positive Tumors Imaging

Roberto Fanelli, Adrien Chastel, Santo Previti et al. · Bioconjugate Chemistry · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases

Clément Morgat, Adrien Chastel, Vincent Molinié et al. · International Journal of Molecular Sciences · 2019 · 22 citations · Full text

Medicine, Oncology, Pathology +17